1.
J Cardiovasc Dev Dis
; 9(6)2022 Jun 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35735807
RESUMO
The race for an ideal cardioplegic solution has remained enthusiastic since the beginning of the modern cardiac surgery era. The Bretschneider solution, belonging to the "intracellular cardioplegic" group, is safe and practical in myocardial protection during ischemic time. Over time, some particular concerns have arisen regarding the effects on cardiac metabolism and postoperative myocardial functioning. This paper reviews the most important standpoints in terms of theoretical and practical analyses.